Voyager Therapeutics Inc (NASDAQ:VYGR)’s Stock Is Sell After More Market Selling

June 14, 2018 - By Ash Ash

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Logo

The stock of Voyager Therapeutics Inc (NASDAQ:VYGR) registered an increase of 0.78% in short interest. VYGR’s total short interest was 2.32 million shares in June as published by FINRA. Its up 0.78% from 2.30 million shares, reported previously. With 334,100 shares average volume, it will take short sellers 7 days to cover their VYGR’s short positions. The short interest to Voyager Therapeutics Inc’s float is 14.02%.

The stock increased 0.23% or $0.05 during the last trading session, reaching $21.64. About 270,346 shares traded. Voyager Therapeutics, Inc. (NASDAQ:VYGR) has risen 112.00% since June 14, 2017 and is uptrending. It has outperformed by 99.43% the S&P500.

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. The company has market cap of $699.43 million. The companyÂ’s lead clinical candidate is the VY-AADC01, which is in Phase Ib clinical trial for the treatment of advanced Parkinson's disease. It currently has negative earnings. The Company’s preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis; VY-HTT01 for HuntingtonÂ’s disease; VY-FXN01 for Friedreich's ataxia; VY-TAU01, AlzheimerÂ’s disease; and VY-NAV01 for severe chronic pain.

More notable recent Voyager Therapeutics, Inc. (NASDAQ:VYGR) news were published by: Globenewswire.com which released: “Voyager Therapeutics Announces Management Change” on May 29, 2018, also Seekingalpha.com with their article: “Premarket analyst action – healthcare” published on June 04, 2018, Nasdaq.com published: “Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual …” on May 18, 2018. More interesting news about Voyager Therapeutics, Inc. (NASDAQ:VYGR) were released by: Streetinsider.com and their article: “UPDATE: HC Wainwright Starts Voyager Therapeutics (VYGR) at Buy” published on June 04, 2018 as well as Investorplace.com‘s news article titled: “7 Strong Buy Stocks Analysts Are Upgrading Now, Including Facebook, Inc.” with publication date: June 13, 2018.

Voyager Therapeutics, Inc. (NASDAQ:VYGR) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: